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Background. Cellular function, cell viability and the cytokine network of
human monocytes are influenced by the specific composition of peritoneal
dialysis (PD) fluids. In an in vitro study using isolated human blood
monocytes, we investigated the effect of peritoneal dialysates containing
amino acids (Amino) or glucose polymer (Glu-poly) instead of glucose
(Glu) as the osmotic agent, and bicarbonate (Bic) or PBS instead of
lactate (Lac) as a buffer.
Methods. The following parameters were studied: mitochondrial dehy-
drogenase activity (using the MTT assay), interleukin (IL)-6 and IL-8
release (ELISA) and cellular IL-6 mRNA expression after lipopolysac-
charide (LPS) stimulation (using RT-PCR). FACS flow cytometry with
annexin V and propidium iodide as markers and fluorescence microscopic
methods were used to study the effects of the test fluids on cell necrosis
and apoptosis.
Results. Glu/Lac pH 5.5 and Glu-poly/PBS pH 7.4 both significantly
reduced mitochondrial dehydrogenase activity by more than 50% after 60
minutes of incubation (30.5 6 7.6%, 42.5 6 6.5%, referred to RPMI 1640
as 100%). Amino/Bic and Glu/Bic were both superior (MTT assay .
63%). The rate of necrotic cells after 15 minutes of incubation measured
by FACS was mostly increased with Glu/Lac pH 5.5 (29.9 6 4.0%). The
rate of apoptotic cells, however, was not significantly different between the
test solutions. The concentration of IL-6 in the supernatant of stimulated
monocytes was highest with Glu/Bic (1023 6 278 pg/ml) and Amino/Bic
(776 6 296 pg/ml) and lowest with Glu/Lac pH 5.5 (46 6 22 pg/ml) and
Glu-poly/PBS (32 6 13 pg/ml). IL-8 release from stimulated monocytes
showed a similar pattern. Glu-poly/PBS showed a suppressive effect on
IL-6 mRNA expression (ratio IL-6/b-Actin, 0.4 6 0.25 vs. RPMI 1.5 6
3.6).
Conclusions. Bicarbonate buffered solutions both with glucose or amino
acids as osmotic agents were superior when regarding cell metabolism,
viability and cytokine release, while lactate buffered solutions and Glu-
poly/PBS showed some reduced biocompatibility pattern for monocytes in
vitro.
Continuous ambulatory peritoneal dialysis (CAPD) as a
renal replacement therapy has been established as a safe
and widely applied method. Despite continuous improve-
ment of the technical equipment, peritonitis is still an
important problem and the major reason for system failure.
Peritonitis is associated with an increase in peritoneal
permeability [1, 2], loss of ultrafiltration und in some cases
sclerosis of the peritoneum [3]. Therefore, with regard to
short-term and long-term outcome it remains an important
issue to further reduce the rate of peritonitis and to
improve cellular biocompatibility of the dialysate.
The local host defense mechanisms within the peritoneal
cavity play a pivotal role for the prevention of peritoneal
infection. Since the normal peritoneal system in healthy
subjects can overcome some bacterial contamination (for
example, during surgery) without developing peritonitis,
the peritoneal dialysis (PD) patient is highly susceptible to
minor system contamination [4]. Negative effects of PD
fluids on cellular host defense of monocytes are well
known. Lactate as a buffer substance, a low pH value and
high osmolality impair cellular function and viability (such
as, measured by phagocytosis activity, cellular ATP content
or LDH release) [5–7]. The same can be found for the
release of inflammatory interleukins within the cytokine
network [5, 7]. In the peritoneal cavity an equilibrium
between the fresh dialysate and the blood compartment is
reached via diffusion between 15 and 30 minutes (concern-
ing pH) and several hours (concerning osmotic agents and
peptides/proteins from the serum). However, the early
phase when undiluted dialysate is instilled into the perito-
neum seems to be most harmful [6].
Interleukin (IL)-6 and IL-8 are important mediators of
the inflammatory response. Besides mesothelial cells, mac-
rophages represent the major source of IL-6 [8] within the
peritoneal cavity. Interperitoneal IL-6 might have a mod-
ulating effect on the inflammatory cascade and has a
potential permeablitiy increasing effect on the peritoneum
[9]. IL-8 is a chemotactic cytokine with proinflammatory
and growth-promoting activities [10]. It is released by a
variety of cell types, mainly by monocytes/macrophages
[11]. IL-8 exhibits potent chemotactic activity for neutro-
phils [12], but it is also a chemoattractant factor for
T-lymphocytes [13] and basophils [14]. Both cytokines are
important promoters of cellular host defence.
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While conventional markers such as the 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test,
adenosine triphosphate (ATP) assay and lactate dehydro-
genase (LDH) release have been studied as global markers
for cell viability, little is known about the influence of
dialysates on apoptosis. Most cells from higher Eukaryotae
have the ability for self-destruction by activation of an
intrinsic cellular suicide program when they are no longer
needed or have become seriously damaged. This normal
physiological process is referred to as programmed cell
death (apoptosis) [15]. Apoptosis is characterized by chro-
matin condensation, membrane blebbing, nuclear and cy-
toplasmatic shrinkage, and the generation of DNA frag-
ments through the activation of endogenous endonuclease
without generating an inflammatory response. This is in
contrast to the type of cell death known as necrosis, which
is characterized by cell lysis and activation of a local
inflammatory response [15–19].
Little is known thus far about the influence of amino
acids or polyglucose as osmotic agents or different buffers
on the mentioned parameters. Amino acids and polyglu-
cose have gained increasing clinical interest for indications
as malnutrition or loss of ultrafiltration. Bicarbonate has
proven to be a superior buffer in combination with glucose
with regard to biocompatibility, but the effects in combina-
tion with amino acids are still open. The current in vitro
study aimed at characterizing the effects of alternative
osmotic agents and buffers on monocyte function.
METHODS
COMPOSITION OF TEST SOLUTIONS AND
CONTROL MEDIUM RPMI 1640
Six test solutions were investigated: glucose/lactate (Glu/
Lac) pH 5.5 and pH 7.5; glucose/bicarbonate (Glu/Bic) pH
7.5; amino acid/bicarbonate (Amino/Bic) pH 7.5; amino
acid/PBS buffer (Amino/PBS) pH 7.5; glucose polymer/
PBS-buffer (Glu-poly/PBS) pH 7.4; and RPMI 1640, PBS
buffer as an internal control media (Table 1). PBS buffer
pH 7.4 proved to be a simple medium with good biocom-
patibility patterns according to the parameters tested. It
was therefore used as an internal reference in addition to
RPMI 1640. Amino acids and Glu-poly were combined
with this medium to focus on the specific effects of the
osmotic agent when combining with a clearly superior
buffer system (though not suited in this form for clinical
application).
Glucose, glucose polymer (dextrin), amino acids and
L-lactic acid were supplied with high purity from Sigma
(Deisenhofen, Germany). An 8.4% sodium hydrogen bicar-
bonate solution and PBS were supplied from Pharma
Halmen GmbH (Halmen, Germany). All test solutions
were sterile filtered with a 0.45 mm filter and subsequently
with a 0.2 mm pyrogen-free filter (Satorius AG, Go¨ttingen,
Germany).
Endotoxin-assay
The endotoxin concentration in all solution was mea-
sured with the Limulus Amebocyte Lysate assay, QCL-100
(Bio-Whittaker, Walkersville, USA; Boehringer Ingelheim,
Germany). In all PD test solutions and RPMI the endo-
toxin level was determined to be low (#2 U/liter).
Cells and culture conditions
Human blood monocytes were obtained from healthy
donors (buffy coats). Mononuclear cells were isolated by
density gradient centrifugation on Ficoll-Paque (Pharmacia
Biotech, Sweden), according to Bo¨yum [20]. Two 3 106/ml
cells in 50 ml RPMI 1640 medium (Biochrom, Germany)
with supplements [10% fetal calf serum (FCS; Gibco BRL,
Scotland, UK), 2 mM L-glutamine (Gibco BRL), 0.05 IU/ml
penicillin and 0.05 mg/ml streptomycin (ICN, USA)] were
cultured in 175 cm2 tissue culture flasks (Becton Dickinson,
Table 1. Composition of the control media and test solutions
Composition
Reference media Test solutions
RPMI 1640 PBS Amino/Bic Amino/PBS Glu/Bic
Glu/Lac
pH 5.5
Glu/Lac
pH 7.5
Glu-poly/
PBS
Amino acid g/liter 1 10a 10a
Glucose g/liter 2 13.6 13.6 13.6
Lactate mmol/liter 40 40
Bicarbonate mmol/liter 23.8 34 34
Anorg. phosphate mmol/liter 5.6 11.3 9.9 8.8
Glucose polymer
(molecular wt 15000) g/liter
75
Sodium mmol/liter 138 146 134 154 134 134 137 148
Calcium mmol/liter 0.9 1.25 1.25 1.25 1.25
Magnesium mmol/liter 0.4 0.5 0.5 0.25 0.25
Chloride mmol/liter 108 139 103 143 103 104 104 137
Osmolality mosm/kg 290 290 369 364 361 358 360 318
pH value 7.5 7.4 7.5 7.5 7.5 5.5 7.5 7.4
Abbreviations are in the Appendix.
a Composition of 70% essential amino acids and 30% nonessential amino acids
Plum et al: Effect of new PD solutions on monocytic cell viability 225
NJ, USA) in an atmosphere of 5% CO2 at 37°C for two
hours. Lymphocytes were removed by washing and mono-
cytes were detached by gently shaking at 4°C. A total of
90.1 6 4.4% of the cells were determined to be viable by
the trypan blue exclusion test; 93% 6 4.4% of the isolated
cells were monocytes, according to peroxidase staining
using benzidine dihydrochloride (Sigma, Deisenhofen,
Germany).
Incubation procedure
One milliliter of cell suspension (8 to 10 3 106 mono-
cytes) in PBS was incubated with 25 ml of the test fluids
(Table 1) for 15 minutes at 37°C, 5% CO2 in 75 cm
2 tissue
culture flasks and stimulated with 10 mg/ml LPS (E. coli
serotype 055/B5; Sigma, Deisenhofen, Germany). The test
fluids were warm and pCO2 equilibrated (after standing in
the incubator) when the pH was adjusted. PBS and RPMI
(without supplements or FCS) were used as reference
media for the fresh dialysates. After 15 minutes of incuba-
tion with the test fluids (except for the MTT assay, where
intervals between 5 to 60 min were evaluated) 26 ml RPMI
1640 and 20% FCS was added, and incubation was contin-
ued for 16 hours (recovery period). All media had a
physiological pH value and an osmolality between 290 and
369 mOsm/kg after addition of RPMI. The pH of the media
after incubation in the CO2 atmosphere was controlled and
did not significantly decrease with time (,0.3 pH units
after 16 hr). The same incubation procedure was applied
for the MTT assay, apoptosis/necrosis assay and cytokine
measurement.
MTT assay
The assay relies on the cleavage of the yellow tetrazolium
salt MTT to purple formazan crystals by succinate-dehy-
drogenase activity in active mitochonodria [21]. Blood
monocytes were incubated for 5 to 60 minutes in the
undiluted test fluids (or RPMI as the reference) followed
by the incubation scheme as described above. After 16
hours recovery in RPMI plus supplements 1 3 106 mono-
cytes were incubated with the MTT solution for further
four hours at 37°C, 5% CO2. Ten percent SDS was then
added and the culture plates were incubated overnight.
Formazan crystals were solubilized and the generation was
quantified using a spectrophotometer [22]. The extinction
coefficient of RPMI 1640 was referred to as 100%. The
data from monocytes submitted to a freeze/thaw cycle and
incubated with RPMI served as a negative control.
Apoptosis and necrosis assays
FACS. Cell staining was performed with fluorescein
isothiocyanate (FITC)-labeled annexin V and propidium
iodide (PI) [18, 19]. Early stages of apoptosis (without loss
of cell membrane integrity) are characterizied by the
translocation of phosphatidylserine (PS) from the inner
side of the plasma membrane to the outer layer [18].
Annexin V is a Ca21 dependent phospholipid-binding
protein with high affinity for PS [19]. After the incubation
procedure described above monocytes were washed with an
ice-cold electrolyte solution (Pharmacia, Erlangen, Ger-
many) and resuspended in cold diluted binding buffer
(Ho¨lzel Diagnostika, Ko¨ln, Germany) at a concentration of
106 cells/ml. A total of 440 ml of the cell suspension was
incubated with 10 ml of the FITC-labeled annexin V (final
concentration 2 mg/ml; Ho¨lzel Diagnostika) and 50 ml
propidium iodide (final concentration 1 mg/ml) for 10
minutes in the dark at 4°C. The cells were analyzed by
FACScan flowcytometry (FACSort; Becton Dickinson,
USA). The gate selected corresponded to monocytes ac-
cording to the dot-blot histogram, and 10,000 to 50,000
blood monocytes were counted. The differentiation of
cellular distribution was received by a contour line repre-
sentation. The inter- and intra-assay variation coefficient
was , 6% (N 5 5). RPMI served as the reference medium.
A positive control for the induction of apoptosis was
introduced by a murine monoclonal anti-Apo-1/Fas IgG
antibody (Ho¨lzel Diagnostika) at a concentration of 1
mg/ml added to Ringer’s solution for two hours at 4°C.
AO staining, TUNEL assay. The validity of the results
concerning the incidence of apotosis and necrosis was
controlled for by investigating an aliquot of the cells by
fluorescence and light microscopy. Two 3 106 cells were
incubated on ice with acridin orange (Sigma) for 15 min-
utes at a concentration of 10 mg/ml [23]. The cellular shape
and typical color was judged under UV light according to
nuclear condensation/fragmentation and cytoplasma con-
densation. The ratio of cells with these changes was evalu-
ated semiquantitatively.
Additionally enzymatic in situ labeling of apoptosis-
induced DNA strand breaks was carried out by using a kit
based on the TdT-mediated dUTP nick end labeling
(TUNEL) method (In Situ Cell Death Detection Kit,
Fluorescin, #1684795; Boehringer Mannheim, Germany).
The test was performed after the usual recovery period of
16 hours. TUNEL positive nuclei were observed and
counted in fluorescent micrographs. A positive control was
introduced by treating permabilized cells with micrococcal
DNase I (10 mg/ml, 10 min).
Cell membrane disruption as a sign of necrosis (or
occurring in the late phase of apotosis, that is, secondary
necrosis) was tested by vital staining with trypan blue.
The reliability of the FACS results was controlled for by
these microscopic methods.
Cytokines
The concentration of IL-6 and IL-8 was determined in
the supernatants of monocytes (from buffy coats) after 16
hours of incubation (Human IL-6 and IL-8, DuoSeTy;
Genzyme, USA). Cells were stimulated with 10 mg/ml LPS.
Unstimulated monocytes in RPMI served as a negative
control. Response curves for LPS-induced cytokine release
Plum et al: Effect of new PD solutions on monocytic cell viability226
were established during the initial time-course experiments
with incubation periods between 0 hours and 48 hours, and
showed that a 16 hour incubation/stimulation was well
suited for the measurement of mRNA expression and
cytokine release. Activated macrophages isolated from the
effluent of three patients with peritonitis (staphylococcus
peritonitis, cells isolated after a six hour dwell before the
onset of antibiotic treatment) served as a positive control
for the adequacy of LPS stimulation. The lower detection
limit of the ELISAs was 0.156 pg/ml and 15.6 pg/ml,
respectively. The specifity of all assays inculding potential
martix effects (dialysates) was tested for by sample spiking
and dilution. Interference between the test solutions and
the ELISA system was excluded and accuracy of the assay
was controlled. No interference with the test solutions
could be found. Inter- and intra-assay variation coefficient
was , 10% (N 5 10).
RNA isolation
Total RNA was extracted from cultured cells by the
Trizoly reagent (Gibco BRL). RNA isolation was per-
formed according to Chomczynski and Sacchi [24]. RNA
was quantified by measuring optical density at 260 and 280
nm. Total RNA obtained was 10 to 15 mg/5 to 10 3 106
cells.
Reverse transcription and polymerase chain reaction
amplification
For the RT-PCR assay, 1.5 mg total RNA was reverse
transcribed into cDNA by using first-strand cDNA Synthe-
sis Kit (Pharmacia Biotech, Freiburg, Germany). The tubes
were incubated at 37°C for one hour and the reverse
transcriptase was inactivated by a 10 minutes incubation at
70°C. Ten microliters of reverse transcribed RNA (100 ng
cDNA) was amplified by PCR in a total volume of 50 ml
using 1 U Taq-Polymerase (Pharmacia Biotech, Freiburg,
Germany), 100 mM dNTPs (Boehringer Mannheim) and 25
pmol of each primer in PCR buffer. Sense primers for
b-actin were [25] 59-AGA GAT GGC CAC GGC TGC
TT-39, and antisense primers were 59-ATT TGC GGT
GGA CGA TGG AG-39, which yielded a 406 base-pair
PCR product. Sense primers for GAPDH were 59-ACA
GTG CAC TCT GGA CAG T-39, and antisense primers
were 59-TCC AGC TGC AGT GTG TCC A-39, which
yielded a 265 base-pair PCR product. Sense primers for
IL-6 were [26] 59-GCT ACA TTT GCC GAA GAG CC-39,
and antisense primers were 59-TAC ATC CCT CGA CGG
ATC TC-39, which yielded a 456 base-pair PCR product.
cDNA was amplified in a thermal cycler (PTC-100y;
Biozym, USA). PCR conditions were established by RNA
(cDNA), primer and enzyme (Taq-DNA-polymerase) titra-
tion, before the amplification reactions. Twenty microliters
of each reaction PCR product were loaded onto a 2%
agarose gel containing 0.5 mg/ml ethidium bromide. The
signal intensity of the PCR products was quantified by
UV-Light with a CCD-Camera (Herolab, Wiesloch, Ger-
many). The IL-6 specific mRNA level was calculated by the
ratios of IL-6 and b-actin or GAPDH as endogenous
standards. mRNA expression in unstimulated monocytes
(RPMI, without LPS) and activated macrophages from the
peritoneal effluent of patients with peritonitis served as
control.
Data analysis
All data are expressed as mean 6 SD. Statistical signifi-
cance was calculated using the Student’s t-test, P values less
than 0.05 were considered to be significant. For multiple
comparisons Bonferroni correction was applied.
RESULTS
Time dependent effects of dialysis fluids on cell viablity
With the progression of incubation time (5, 15, 30, 45, 60
min), the mitochondrial dehydrogenase activity (MTT test)
decreased in a different degree for the dialysis fluids tested
(Fig. 1). Glu/Bic pH 7.5, Amino/Bic pH 7.5 and Amino/PBS
pH 7.5 showed the highest mitochondrial dehydrogenase
activity, whereas Glu/Lac pH 7.5, Glu-poly/PBS pH 7.4 and
Glu/Lac pH 5.5 showed the lowest mitochondrial dehydro-
genase activity at all incubation times. Even after five
minutes of incubation, the MTT test activity was reduced to
62 6 14% with Glu/Lac pH 7.5 (P , 0.05, vs. RPMI) and
to 52 6 7% with Glu/Lac pH 5.5 (P , 0.001, vs. RPMI). A
low activity was also measured for Glu-poly/PBS pH 7.4
with 55 6 8% (P , 0.001, vs. RPMI).
Mitochondrial dehydrogenase activity after 45 minutes of
incubation time was significantly reduced for all tested
dialysis fluids compared to the control medium RPMI.
After 60 minutes of incubation the dehydrogenase activity
dropped to 73 6 11% for Glu/Bic pH 7.5 (P , 0.01, vs.
RPMI), but was only 31 6 8% for Glu/Lac pH 5.5 (P ,
0.001, vs. RPMI). At all incubation times Glu/Bic and
Amino/Bic fell nearest to the reference medium RPMI.
Effects of alternative dialysis solutions on apoptosis and
necrosis
The rate of apoptotic cells after incubation with the test
solutions was relatively uniform, and ranged between 20
and 28% with no significant differences between the fluids
(Fig. 2). On the other hand, major differences could be
registered for the rate of necrotic cells between the control
medium (4.1 6 1.1%) and the test solutions. The rate of
necrotic cells after incubation with Glu/Bic pH 7.5 (7.1 6
2.7%), Amino/Bic pH 7.5 (7.9 6 3.1%) and Amino/PBS pH
7.5 (7.8 6 2.9%) was similar to that of RPMI (NS). Glu/Lac
pH 7.5 (10.4 6 6.0) and Glu-poly/PBS (9.9 6 2.2) were
slightly elevated compared to RPMI (P , 0.05). A very
high incidence of necrotic cells, however, was detected for
Glu/Lac pH 5.5 (29.9 6 4.0%; P , 0.01).
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Supravital staining with acridin orange using fluores-
cence microscopy confirmed this order of cell cytoxicity of
the different fluids with the highest degree of cell necrosis
found with Glu/Lac pH 5.5. Partial nuclear condensation
but otherwise normal appearance was considered as an
early sign of apoptosis. In subsequent phases of apoptosis
nuclear condensation increased and the nucleus became
yellowish. Characteristic bud-like cell surface protuber-
ances could be observed. Necrotic cells showed a swollen or
disrupted shape with a reddish appearance of the cyto-
plasma and the nucleus. A red fluorescence could also be
observed in disintegrated cells as a result of late apoptosis,
and thus could not always be distinguished from primary
necrosis (Fig. 3). The rate of early apototic cells (with an
intact cell membrane, corresponding to a negative PI
staining in the FACS analysis) was evaluated. This ratio was
nearly on the same level after 16 hours of incubation with
the test fluids and ranged between 22% and 32%.
TUNEL positive cells had a bright nuclear fluorescence.
The positive controls after the deliberate treatment with
DNase I showed labeling of nearly all nuclei. The ratio of
TUNEL positive cells in dialysate treated cultures varied
between 24 and 35% (difference, NS; Fig. 3).
Influence of different dialysis solutions on the expression
of housekeeping genes (b-actin, GAPDH)
The cellular b-actin mRNA expression after 15 minutes
of incubation with the test fluids differed markedly (Figs. 4
and 5). While b-actin mRNA levels of Glu/Bic pH 7.5
(99 6 2%), Amino/Bic pH 7.5 (90 6 6%) and Amino/PBS
pH 7.5 (90 6 4%) were similar to the control medium
(RPMI), we found a clear suppression for Glu/Lac pH 7.5
(68 6 14%, P , 0.05), Glu-poly/PBS pH 7.4 (34 6 15%,
P , 0.005) and Glu/Lac pH 5.5 (11 6 6%, P , 0.001). A
parallel finding was observed for GAPDH mRNA expres-
sion after 15 minutes of incubation with the mentioned
dialysates (data not shown). There was a clear correlation
between mitochondrial dehydrogenase activity (measured
by MTT-assay) and b-actin specific mRNA expression (r 5
0.877, P , 0.005).
Effect of alternative dialysis solutions on IL-6 gene
transcription
The ratio for IL-6/b-actin mRNA level was found to
be . 0.6 for all tested fluids except Glu-poly/PBS pH 7.4,
which showed a depressed IL-6/b-actin ratio of 0.2 (P ,
0.05). The same pattern was noted when relating IL-6 to
GAPDH mRNA expression (Fig. 5).
IL-6 and IL-8 release from LPS stimulated monocytes
IL-6 concentration in the cell supernatants after LPS
stimulation was highest in the control media RPMI 1640
(1004 6 354 pg/ml) and PBS (1154 6 348 pg/ml). It was
followed by Glu/Bic (1023 6 278 pg/ml), Amino/PBS
(1011 6 226 pg/ml) and Amino/Bic (796 6 296 pg/ml),
Fig. 1. Mitochondrial dehydrogenase activity measured in monocytes by the MTT assay. The change in enzyme activity on incubation with alternative
dialysis solutions (5, 15, 30, 45, 60 min) was referred to RPMI 1640 as 100%. Abbreviation NK is the negative control, where the macrophages were
killed by a preswitched freeze/thaw cycle and incubated with RPMI. Incubation with PBS buffer for five minutes was used as a positive control. All values
are mean 6 SD (N 5 4). Statistical significance of the difference between control medium (RPMI 1640) and experimental fluids is given, *P , 0.05.
Symbols are: (M) Glu/Bic pH 7.5; (z) Amino/Bic 7.5; (p) Amino/PBS pH 7.5; ([squp]) Glu/Lac, pH 7.5; (n) Glu-poly/PBS pH 7.4; (f) Glu/Lac pH 5.5.
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which did not differ significantly. A low release of IL-6 was
found for Glu/Lac pH 7.5 (267 6 192 pg/ml), Glu/Lac pH
5.5 (46 6 22 pg/ml) and 7.5% Glu-poly/PBS (32 6 13
pg/ml). The lactate buffered glucose solution (Glu/Lac),
even adjusted to a neutral pH of 7.5, was still inferior with
regard to IL-6 release when compared to the bicarbonate
buffered pendant Glu/Bic pH 7.5 (1023 pg/ml vs. 267 pg/ml,
P , 0.01; Fig. 6).
The concentrations of IL-8 were about 10 times higher
compared to IL-6 in the control media RPMI 1640 (9630
pg/ml 6 815) and PBS (8176 6 681 pg/ml). The pattern of
IL-8 release was similar to that of IL-6, but the differences
between the fluids were somewhat less marked. Glu/Bic
(9749 pg/ml 6 2038), Amino/Bic (9399 pg/ml 6 1560),
Amino/PBS (9693 pg/ml 6 1301) and Glu/Lac pH 7.5 (9333
pg/ml 6 714) did not differ from the control medium. The
7.5% glucose polymer (3031 pg/ml 6 1586) and Glu/Lac
pH 5.5 (2991 pg/ml 6 2143) showed a significantly reduced
release (Fig. 6).
DISCUSSION
We studied the in vitro effects of alternative dialysate
fluids that appear promising for clinical application. Pe-
ripheral blood monocytes were chosen for testing purposes
in this study, because they are precursors of macrophages,
available in high numbers, and have not been exposed to
the potentially toxic dialysis fluids prior to study. A 5 to 60
minute lasting incubation of macrophages in undiluted
dialysis fluid was tested beforehand, and appeared to be
suited to simulate the in vivo situation with regard to pH
influences or buffer systems. After 15 to 30 minutes, an
equilibration of pH is reached in the peritoneal cavity of
PD patients using standard Glu/Lac pH 5.5 solution [27].
On the other hand, osmolarity may be still increased after
Fig. 2. Flow cytometric analysis of apoptotic and necrotic cells. Blood mononuclear cells were incubated for 15 minutes with the test dialysates. The
cells (106/ml) were washed with bindung buffer and directly analyzed after addition of Annexin VFITC and propidium iodide. Abbreviations in the boxes
are: I, necrotic cells; II, intact cells; III, apoptotic cells. The bars indicate the relative distribution of apototic (M) and necrotic (f) cells measured by
flow cytometry. A positive control for apoptosis was introduced by incubating MNCs with a monoclonal anti-Apo-1 antibody for two hours. Examples
of orginal plots are demonstrated in the top half of this figure. All values are mean 6 SD (N 5 5).
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Fig. 3. Fluorescence microscopic pictures of unfixed macrophages stained with 10 mg/ml of AO, excitation at 490 nm (left side). Cells were incubated
with RPMI control medium (A), Glu/Bic (B) or Glu/Lac (C). Viable cells displayed a green cytoplasmic fluorescence and some weaker nuclear
fluorescence (double stranded DNA). Early apopotic cells showed nuclear fragmentation and condensation. In later phases of apoptosis nuclear
condensation increased and the nucleus became yellowish. Cytoplasmic membrane blebbing increased (green buds). Necrotic cells showed a swollen
cytoplasma with nuclear disintegration. Disrupted cells had a reddish appearance of the nucleus and the cytoplasma. These latter findings were
predominantly observed with Glu/Lac (C). The cell membrane integrity was additionally tested by the trypan blue exclusion test (panel D, RPMI; E,
Glu/Bic; F, Glu/Lac). Apoptosis detected by TUNEL-labeled nuclei of macrophages (right side). Pseudo-TUNEL-positive control cells were induced
by DNase I treatment (G). Cultures were incubated with Glu/Bic (H) or conventional dialysis solution Glu/Lac (I). Bar 5 20 mm
a four hour dwell [27], and nutritional factors like hor-
mones and proteins also accumulate slowly in the PD fluid
[28]. For this purpose we used a coincubation design with
undiluted dialysate exposure of the cells for 15 minutes
(except for the MTT assay, where intervals between 5 to 60
min were evaluated) followed by a 1:1 dilution with RPMI
and FCS for 16 hours. This procedure may simulate the in
vivo equilibration more closely than a preincubation sched-
ule.
On incubation times between five minutes to 60 minutes,
the mitochondrial dehydrogenase activity progressively de-
creased with the test fluids compared to the control me-
dium. However, according to the MTT test, the aerobic cell
metabolism was predominantly compromised by lactate
buffer in combination with a low pH. The clinical standard
dialysate (1.36% Glu/Lac pH 5.5) resulted in a marked loss
of mitochondrial dehydrogenase activity compared to
RPMI at all incubation times. We observed a clear parallel
between the dehydrogenase activity and the decrease of
cellular b-actin mRNA expression after 15 minutes of
incubation (Fig. 7). Principally, semiquantitative RT-PCR
refers to a constant (unaltered) expression of a housekeep-
ing gene. To verify the fact of a reduced b-actin mRNA
transcription with some dialysates we also evaluated an-
other housekeeping gene (GAPDH) in terms of mRNA
levels, but the results were similar to that of b-actin,
indicating severe cellular damage. The correlation between
the mitochondrial dehydrogenase activity and the specific
b-actin mRNA level was highly significant (r 5 0.877, P 5
0.005), also suggesting that a toxic effect of some test fluids
resulted in reduced cellular mRNA transcripion or degra-
dation. Necrotic cells are characterized by cell lysis [15, 16]
and subsequently mRNA disintegration including house-
keeping genes. To further clarify this situation we studied
the rate of necrotic and apototic cells by FACS. After
incubation with Glu/Lac pH 5.5, Glu/Lac pH 7.5 and 7.5%
Glu-poly/PBS pH 7.4, we could show that the rate of
necrotic cells was significantly increased compared to the
control medium. The early state of apotosis as a form of
programmed cell death (measured by the translocation of
phophatidylserine to the cell surface), however, was not
significantly different between the tested solutions. We
quantitatively evaluated the apotosis/necrosis rate by FACS
and could confirm our results by supravital acridine orange
staining and the TUNEL assay. The rate of necrosis
compared to the rate of apotosis registered, however, is
also somewhat dependent on the incubation conditions.
Cell lysis appearing as necrosis can be the final result of late
apoptosis. Shorter incubation times with the test fluids
indeed increased the ratio of apoptosis with a maximum
Fig. 4. Mitochondrial dehydrogenase activity (M; MTT assay) and b-actin specific mRNA expression (f; measured by RT-PCR) in blood monocytes
incubated for 15 minutes with different dialysis solutions. Recovery period of 16 hours. b-actin expression was not different in non LPS stimulated cells
or macrophages from peritonitis patients (see also Fig. 5). All values are mean 6 SD (N 5 4). Difference tested between control medium (RPMI 1640)
and test fluids, *P , 0.05. Correlation of b-actin/MTT, r 5 0.877; P , 0.005.
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being noted after four to eight hours. Nevertheless, the
high rates of cell necrosis occurring in rather early stages of
incubation underline the high cytotoxity of some fluids.
One reason for the rapid loss of cell viability and the high
incidence of necrosis may be a low intracellular pH. It has
been shown that the combination of low pH and lactate as
a buffer reduces cell viability and phagocytosis activity in
leukocytes [5–7, 29]. This was attributed to a fast and
sustained intracellular drop of pH and a subsequent inhi-
bition of pH depending enzymes [6, 30, 31]. By this
mechanism a prolonged disturbance of cellular host de-
fence may be provoked (even after intraperitoneal pH
equilibration) [32, 33].
As mentioned above, the b-actin and GAPDH house-
keeping mRNA expression (measured by RT-PCR) was
reduced with Glu/Lac pH 5.5. On a post-transcriptional
level this may explain the low concentration of IL-6 mea-
sured in the cell supernatant for this dialysate. The IL-6/b-
actin mRNA ratio, however, was not changed. We can
assume, therefore, that transcriptional modulation is not
responsible for the low secretion of IL-6 after LPS stimu-
lation, but direct cytotoxicity of some dialysates that leads
to cell damage and necrosis (Fig. 7). The expression of IL-6
mRNA induced by LPS and the release of IL-6/IL-8 in our
test system was comparable to that found in activated
peritoneal macrophages from patients with bacterial peri-
tonitis, thereby indicating an appropriate in vivo stimula-
tion.
Glucose polymer exerts a colloid osmotic effect giving
sustained ultrafiltration due to a long lasting colloid os-
motic gradient [34–36]. We found that 7.5% glucose poly-
mer decreased cell viability, but also altered IL-6 mRNA
expression in a specific manner. The test solution with 7.5%
glucose polymer pH 7.4 showed a better cell viability
compared to Glu/Lac pH 5.5 (with regard to MTT-assay
and necrosis/apotosis assay), but was still inferior to Glu/
Bic or Amino/Bic. Glucose polymer demonstrated an ad-
ditional suppressive effect on IL-6 mRNA expression (IL-
6/b-actin). This circumstance may explain the very low
secretion of IL-6 into the cell supernatant upon LPS
stimulation. Cell function may not only be compromised by
hyperosmotic solutions as it is known from concentrated
Fig. 5. Effect of alternative dialysates on b-actin and IL-6 mRNA expression in blood moncytes. b-Actin specific mRNA level (upper panel) and IL-6
mRNA (lower panel) were determined by RT-PCR. A total of 20 ml of each PCR reaction product was loaded onto a agarose gel containing ethidium
bromide. Monocytes were activated with LPS (10 mg/ml). LPS and non-LPS stimulated blood moncytes incubated in RPMI served as controls. Activated
macrophages from peritonitis patients were introduced as a control for the adequacy of LPS stimulation. All values are mean 6 SD (N 5 6). The
IL-6/b-actin ratio was not different between all dialysates except for 7.5% glucose polymer pH 7.4. *P , 0.05, tested against control medium.
Plum et al: Effect of new PD solutions on monocytic cell viability232
glucose [6], but may also be influenced by a high colloid
osmotic pressure. De Fijter et al showed that peritoneal
macrophages of PD patients had better phagocytotic ca-
pacities and a higher oxidative metabolism after intraperi-
toneal exposure to the glucose polymer solution as com-
pared with glucose monomer fluid [34]. A negative impact,
on the other hand, was described by Liberek et al, who
investigated mesothelial cells and neutrophile granulocytes
[37]. Our results strengthen the impression that glucose
polymer specifically influences the IL-6/IL-8 release of
monocytes. The molecular weight of glucose polymer prep-
arations and the type of branching (1-4, 1-6 glycosidic
binding) could be aspects that influence biocompatibility
patterns. The influence of the degradation products of the
polymer should also be focused on in further studies.
Glu/Bic pH 7.5 and Amino/Bic pH 7.5 yielded the best
results in terms of cell metabolism, viability and cytokine
expression/release. Jo¨rres et al also observed less suppres-
sion of IL-6 gene transcription and release after the
exposure of mononuclear cells (MC) to bicarbonate buff-
ered fluids with a physiological pH [7]. These data are in
accordance to our results [38]. Dobos et al found that
bicarbonate buffered fluids impaired much less neutrophile
granulocyte function concerning phagocytosis, chemotaxis
and change in cytoskeleton [39] compared to lactate solu-
tions. Some benefit of bicarbonate over lactate may prob-
ably exist irrespective of pH [40], as our data comparing
Glu/Lac and Glu/Bic show that both adjusted to a neutral
pH. Chaimovitz et al and Zhou et al demonstrated that a
high lactate concentration, even with a physiological pH
value, resulted in a decreased intracellular pH [41, 42]. In
our experiments the replacement of lactate by bicarbonate
with glucose as well as with amino acids as osmotic agent
resulted in a superior cytokine response and in an improve-
ment of monocytic viability.
For clinical purposes, amino acids appear to be an
Fig. 6. Effect of alternative dialysates on LPS (10 mg/ml) stimulated IL-6 and IL-8 release from isolated blood monocytes (10 3 106). Incubation for
15 minutes with test dialysates, recovery period of 16 hours. Cytokine concentrations were measured in the cell supernatant after 16 hours by ELISA.
LPS and non-LPS stimulated blood moncytes incubated in RPMI served as positive and negative controls. Activated macrophages from peritonitis
patients were introduced as a control for the adequacy of LPS stimulation. All values are mean 6 SD (N 5 6).
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equivalent substitute for glucose with regards to dialysate
biocompatiblity. A more widespread use of bicarbonate
should be promoted, even if technical aspects of storage
have to be improved further (such as, double chamber
systems). Glucose polymer fluids appear to be a clinically
attractive alternative in patients with low ultrafilration
(highly permeable peritoneum) or in terms of reducing the
glucose load. The in vitro findings with monocytes with
regards to cell viability and a reduced cytokine release
showed non-ideal conditions. Further ex vivo and in vitro
research is ongoing in our center, with an emphasis on the
effects of glucose polymer on isolated peritoneal macro-
phages after a long intraperitoneal dwell with this fluid.
Biocompatibility research is also needed to examine the
short-term and long-term effects of these new fluids on
resident peritoneal cells (such as, mesothelial cells and
fibroblasts) to determine if they are relevant for sustained
peritoneal membrane integrity.
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APPENDIX
Abbreviations used in this article are: Amino, amino acid dialysate;
ATP, adenosine triphosphate; Bic, bicarbonate dialysate buffer; CAPD,
continuous ambulatory peritoneal dialysis; FCS, fetal calf serum; FITC,
fluorescein isothiocyanate; Glu, glucose dialysate; Glu-poly, glucose poly-
mer (dextrin) dialysate; IL, interleukin; Lac, lactate dialysate buffer; LDH,
lactate dehydrogenase; LPS, lipopolysaccharide; MTT, 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide; PBS, phosphate buffered
saline; PD, peritoneal dialysis; PS, phosphatidylserine; RT-PCR, reverse
transcription-polymerase chain reaction; TUNEL, TdT-mediated dUTP
nick end labeling.
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